Showing results (521-530 of 1,502) with videos related to

Sort By:
Pageof 151
Familial Cancer|July 20, 2007
The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedsideC Richard Boland, Minoru Koi, Dong K Chang, et al.
Familial Cancer|July 20, 2007
Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxisKaren H Lu
Familial Cancer|July 13, 2007
Roles and responsibilities of a medical geneticistWendy S Rubinstein
Familial Cancer|July 13, 2007
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanomaChristian Monnerat, Agnès Chompret, Caroline Kannengiesser, et al.
Familial Cancer|September 2, 2004
Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-upBrita Arver, Aina Haegermark, Ulla Platten, et al.
Familial Cancer|September 2, 2004
A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancerFred H Menko, Gertjan L Kaspers, Gerrit A Meijer, et al.
Familial Cancer|September 2, 2004
Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patientsJin C Kim, Seon A Roh, Kum H Koo, et al.
Familial Cancer|September 2, 2004
Impact of a cancer registry-based genealogy service to support clinical genetics servicesDavid H Brewster, Alison Fordyce, Roger J Black, et al.
Familial Cancer|June 14, 2005
Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriersG Chenevix-Trench, O M Sinilnikova, G Suthers, et al.
Familial Cancer|August 6, 2008
Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelinesJulia Hall, Susan Gray, Roger A'Hern, et al.
Pageof 151